Analysts Could Be Undervaluing This Healthcare Giant's Potential By: Benzinga via Benzinga August 14, 2015 at 09:26 AM EDT In a report published Friday, Piper Jaffray analyst Richard J. Purkiss maintained an Overweight rating on Pfizer Inc. (NYSE: PFE), with ... Read More >> Related Stocks: Pfizer